These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9006735)

  • 1. New drugs to block tumor's blood supply.
    Dickman S
    Ann Oncol; 1996 Nov; 7(9):874-5. PubMed ID: 9006735
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-angiogenesis: biology is the foundation for therapy.
    Gerber HP
    Drug Discov Today; 2003 Apr; 8(8):344-6. PubMed ID: 12681937
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticancer therapy with angiogenesis inhibitors.
    Ghilardi C; Bani MR; Giavazzi R
    Tumori; 2001; 87(6):S14-6. PubMed ID: 11989610
    [No Abstract]   [Full Text] [Related]  

  • 4. The biological basis for antiangiogenic therapy.
    Giavazzi R; Albini A; Bussolino F; DeBraud F; Presta M; Ziche M; Costa A
    Eur J Cancer; 2000 Oct; 36(15):1913-8. PubMed ID: 11000570
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiogenesis research enjoys growth spurt in the 1990s.
    Ziegler J
    J Natl Cancer Inst; 1996 Jun; 88(12):786-8. PubMed ID: 8637041
    [No Abstract]   [Full Text] [Related]  

  • 6. Rocking the foundations of solid tumor growth by attacking the tumor's blood supply.
    Molema G; Griffioen AW
    Immunol Today; 1998 Sep; 19(9):392-4. PubMed ID: 9745201
    [No Abstract]   [Full Text] [Related]  

  • 7. Promises and pitfalls of anti-angiogenic therapy in clinical trials.
    McCarty MF; Liu W; Fan F; Parikh A; Reimuth N; Stoeltzing O; Ellis LM
    Trends Mol Med; 2003 Feb; 9(2):53-8. PubMed ID: 12615038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New molecular target of cancer therapy--angiogenesis regulator VEGF].
    Toi M; Ueno T; Tominaga T
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2202-6. PubMed ID: 9422062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of angiogenesis in a clinical perspective.
    Voest EE
    Anticancer Drugs; 1996 Sep; 7(7):723-7. PubMed ID: 8949981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building a better Trap.
    Hood JD; Cheresh DA
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8624-5. PubMed ID: 12861079
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiogenesis and angiogenic mediators in haematological malignancies.
    Mangi MH; Newland AC
    Br J Haematol; 2000 Oct; 111(1):43-51. PubMed ID: 11091181
    [No Abstract]   [Full Text] [Related]  

  • 12. Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.
    Hayes AJ; Li LY; Lippman ME
    BMJ; 1999 Mar; 318(7187):853-6. PubMed ID: 10092266
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer.
    George DJ; Kaelin WG
    N Engl J Med; 2003 Jul; 349(5):419-21. PubMed ID: 12890838
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiangiogenesis: current clinical data and future perspectives.
    Drevs J; Laus C; Medinger M; Schmidt-Gersbach C; Unger C
    Onkologie; 2002 Dec; 25(6):520-7. PubMed ID: 12566896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS
    J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
    Jain RK
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of angiogenic growth factors and their inhibitors.
    Ferrara N; Alitalo K
    Nat Med; 1999 Dec; 5(12):1359-64. PubMed ID: 10581076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking angiogenesis in diabetic retinopathy.
    Bonn D
    Lancet; 1996 Aug; 348(9027):604. PubMed ID: 8815360
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in the use of angiogenesis inhibitors in cancer.
    Pinedo HM
    Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.